Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 12/1/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Kathleen Dungan

Wrong Dr. Kathleen Dungan?

Endocrinologist, Associate Profes...

Local Address:  Ohio , United States
The Ohio State University Wexner Medical Center
555 Metro Place North - Suite 475
Dublin , Ohio 43017
United States

 
Background

Employment History

Education

  • OSU
  • MD
  • MPH
  • M.D.
19 Total References
Web References
"For patients who cannot tolerate or ...
www.biospace.com, 1 Dec 2015 [cached]
"For patients who cannot tolerate or have contraindications to metformin, a sulfonylurea is often prescribed as first-line therapy for type 2 diabetes," said Kathleen Dungan, M.D., endocrinologist, associate professor, The Ohio State University Wexner Medical Center, and lead study author.
...
1 Dungan, K, Weitgasser R, Manghi FP, et. al. Efficacy and Safety of Once Weekly Dulaglutide Added on to Sulfonylurea in Type 2 Diabetes (AWARD-8). Abstract 0219-PD. Presented at 2015 International Diabetes Federation (IDF) World Congress; 30 November 4 December, Vancouver, Canada.
Editorial Team - Endotext
www.endotext.org, 22 July 2015 [cached]
Kathleen Dungan
...
Kathleen Dungan
Associate Professor of Medicine at The Ohio State University Division of Endocrinology, Diabetes and Metabolism. Dr. Dungan attended medical school at OSU and completed her residency and fellowship in 2006 at University of North Carolina. She then returned to OSU where she serves as the division Associate Director of Clinical Services and the director of endocrine clinical trials, and oversees the inpatient diabetes program. She divides her time in clinical care and research in diabetes. Her research focuses on diabetes clinical trials, and ranges from quality improvement, pharmaceutical, and device interventions in the inpatient and outpatient settings. She has presented several times at national meetings such as the ADA and Endocrine Society and has published numerous manuscripts and chapters ranging from glucose monitoring, incretin based therapies, and insulins, to mechanistic and outcomes studies in hospitalized patients. She serves on the editorial board of Diabetes Technology & Therapeutics. She serves as the American Diabetes Association Central Ohio Community Leadership Board president and on the national ADA Scientific Sessions planning committee.
...
Kathleen Dungan
\"The ease of access to this ...
ecysticfibrosisreview.org, 15 Oct 2015 [cached]
\"The ease of access to this evidence-based information ensures that the busy clinician understands today's advances in the care of people with diabetes,\" says Kathleen Dungan, MD, MPH, associate professor, associate division director for clinical services in the Division of Endocrinology of Diabetes and Metabolism at the Ohio State University and one of the program directors for eDiabetes Review.
"For patients who cannot tolerate or ...
www.newswire.ca, 1 Dec 2015 [cached]
"For patients who cannot tolerate or have contraindications to metformin, a sulfonylurea is often prescribed as first-line therapy for type 2 diabetes," said Kathleen Dungan, M.D., endocrinologist, associate professor, The Ohio State University Wexner Medical Center, and lead study author.
"Diabetes is a progressive disease that ...
www.stockhouse.com, 14 June 2014 [cached]
"Diabetes is a progressive disease that affects every patient differently," said Kathleen Dungan, MD, endocrinologist, associate professor, The Ohio State University Wexner Medical Center.
...
Dungan, K, Povedano, S, et al. Efficacy and Safety of Once Weekly Dulaglutide versus Once Daily Liraglutide in Type 2 Diabetes (AWARD-6). Abstract 110-LB. Presented at 74th American Diabetes Association (ADA) Scientific Sessions; June 13-17, 2014; San Francisco, CA. International Diabetes Federation. IDF Diabetes Atlas, 6th edn.Brussels, Belgium: International Diabetes Federation, 2013. http://www.idf.org/diabetesatlas.
Other People with the name "Dungan":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.